Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by SouthernTierTomon Nov 18, 2021 9:54am
81 Views
Post# 34140254

RE:Great expectations

RE:Great expectations Indeed ; - ) ...those "little dickens"...what might "they" be up to??

Perhaps using the bullboared as a "proxy" is in fact a fun exercise..

Afterall Beav...it is "TAX LOSS" season...oh the timing, oh the attention to "de-rail" oh the $hame!

Thanks MM, you seem well aware of the "history / fact / science"..I've heard it can be a good indicator ( financial bio-marker if you will ) og the future..

WHO really knows...do your own homework as they say.  Thanks for the factual content!

"I would also think about the OPEN LABEL structure of the phase 3B trial and the clear ability to produce rather stunning 20%+ absolute efficacy benefits when the "Golden Hour" strikes their mood." -STT

Ya gotta believe their expectation would be to produce Euphas like results, no?
I'm excited about the possibility of 20%+. Any idea what that would be on a relative benefit basis? PMX use compared to Sham in the .6 to .89 group was associated with a 29% relative risk reduction in mortality at 28 days.  And that was with an approx 11% absolute benefit.

I'm not good with math so what would the 20% Absolute Benefit translate into on a relative risk reduction basis?  40% ? more ?  I'd multiply by 2.71 (= 29/10.7) but then I get 54.2 and that doesn't seem right (seems too pumpy for my taste)

MM
<< Previous
Bullboard Posts
Next >>